Rapamycin, the prototypical mTOR inhibitor, was shown in hypertrophy experiments in mice to reduce damage following ischemia-reperfusion injury and myocardial infarction by modulating apoptosis, ERK, and NO signaling (53). This evidence concerns the gene MTOR and myocardial infarction.